Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced it has been selected by Umicore Corporate Research and Development, which is part of global materials technology and recycling company Umicore, ...
AstraZeneca has entered into a licence agreement with RQ Biotechnology Ltd (RQ Bio) for a portfolio of early-stage monoclonal antibodies (mAbs) targeted against SARS-CoV-2, the virus that causes COVID-19. Under the agreement, AstraZeneca has acquired ...
BenevolentAI (Euronext Amsterdam: BAI), a leading clinical-stage AI-enabled drug discovery company, today announces that AstraZeneca has selected an additional novel target for idiopathic pulmonary fibrosis (IPF) for its drug development portfolio, resulting in a milestone ...